ARCHIVES

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

This article is from The Cancer Letter archive.

Vol. 30 No. 46 | December 10, 2004

Download PDF Visit The Full Archive

Related Articles

Flood Asks ACCC for Greater Community Effort

February 14, 1975

Obituaries: Sylvan Green, Donald Gleason

January 23, 2009

AAAS Urges Bush To Continue Funding For Stem Cell Research; ONS Hires Arent Fox.

March 9, 2001

Health Disparities Between Minorities Too Large, Shalala Says

March 27, 1998

CCIRC Disapproves NCOG Renewal, But Carter Plan Appeal To NCAB; Setback For NCI On Regional Groups

March 6, 1981

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

November 26, 2010